Avadel Pharmaceuticals PLC (AVDL)
17.34
-0.04
(-0.23%)
USD |
NASDAQ |
Apr 19, 16:00
17.34
0.00 (0.00%)
After-Hours: 20:00
Avadel Pharmaceuticals Debt to Equity Ratio: 0.00 for Dec. 31, 2023
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.00 |
| September 30, 2023 | 0.1923 |
| June 30, 2023 | 0.1456 |
| March 31, 2023 | -2.978 |
| December 31, 2022 | -6.114 |
| September 30, 2022 | -10.95 |
| June 30, 2022 | -40.31 |
| March 31, 2022 | 2.584 |
| December 31, 2021 | 1.820 |
| September 30, 2021 | 1.436 |
| June 30, 2021 | 1.193 |
| March 31, 2021 | 1.036 |
| December 31, 2020 | 0.7901 |
| September 30, 2020 | 0.739 |
| June 30, 2020 | 0.6857 |
| March 31, 2020 | 3.844 |
| December 31, 2019 | -4.168 |
| September 30, 2019 | -4.457 |
| June 30, 2019 | -6.679 |
| March 31, 2019 | -12.24 |
| December 31, 2018 | 41.67 |
| September 30, 2018 | 1.742 |
| June 30, 2018 | 1.440 |
| March 31, 2018 | 1.285 |
| December 31, 2017 | 0.0031 |
| Date | Value |
|---|---|
| September 30, 2017 | 0.0095 |
| June 30, 2017 | 0.0115 |
| March 31, 2017 | 0.014 |
| December 31, 2016 | 0.0194 |
| September 30, 2016 | 0.0277 |
| June 30, 2016 | 0.0207 |
| March 31, 2016 | 0.0167 |
| December 31, 2015 | 0.0162 |
| September 30, 2015 | |
| June 30, 2015 | 10.98 |
| March 31, 2015 | 5.537 |
| December 31, 2014 | 0.1493 |
| September 30, 2014 | 2.393 |
| June 30, 2014 | 1.511 |
| March 31, 2014 | 0.9556 |
| December 31, 2013 | -8.990 |
| September 30, 2013 | -5.567 |
| June 30, 2013 | -8.423 |
| March 31, 2013 | 2.492 |
| December 31, 2012 | 1.201 |
| September 30, 2012 | |
| June 30, 2012 | 1.964 |
| March 31, 2012 | 1.559 |
| December 31, 2011 | 0.1247 |
| September 30, 2011 | 0.1176 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
-40.31
Minimum
Jun 2022
3.844
Maximum
Mar 2020
-3.221
Average
0.1923
Median
Sep 2023
Debt to Equity Ratio Benchmarks
| Trinity Biotech PLC | -3.116 |
| Medtronic PLC | 0.4851 |
| Jazz Pharmaceuticals PLC | 1.529 |
| Adaptimmune Therapeutics PLC | 0.00 |
| Iterum Therapeutics PLC | -- |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 164.70M |
| Total Liabilities (Quarterly) | 76.96M |
| Shareholders Equity (Quarterly) | 87.74M |
| Current Ratio | 3.641 |
| Net Debt Paydown Yield | 2.15% |